Robitussin cough syrup recalled by Haleon in US due to contamination
Robitussin is frequently used to treat respiratory allergies, flu, cold, fever
Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week.
"Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems," Haleon stated in a notice posted by the Food and Drug Administration, according to CBS.
"Most users are unlikely to experience a serious health problem, but an infection that requiring medical intervention can't be ruled out," the company said.
Robitussin is frequently used to treat respiratory allergies, the common cold, the flu, and hay fever. The following goods are included in the recall, along with their lot numbers and expiration dates:
Robitussin Honey CF Max Day Adult 4oz — T10810 — October 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T08730, T08731, T08732, T08733 — May 31, 2025
Robitussin Honey CF Max Day Adult 8oz — T10808 — September 30, 2025
Robitussin Honey CF Max NT Adult 8oz — T08740, T08742 — June 30, 2026
"Consumers who purchased the recalled products shouldn't use them," Haleon said.
-
Channel 4 to cut hundreds of jobs in major restructuring: What to know
-
Very hot tea and coffee could triple cancer risk, Oxford study warns
-
Google commits $15B to Finnish AI infrastructure, marking its largest-ever European investment
-
Global study reveals nearly 1.7 million deaths linked to second-hand smoke exposure in 2023
-
No ticket? New TSA program lets non-travelers past airport security
-
Singapore raises ministers’ salaries for the first time in 15 years: Here’s why
-
French AI pioneer Mistral secures €3 billion in record-breaking financing round, hitting a $24 billion valuation
-
AI-designed drug also slowed biological aging, study finds